UK drug reg­u­la­tor to restart in­spec­tions at the end of March with a fo­cus on so­cial dis­tanc­ing

The UK’s Med­i­cines and Health­care prod­ucts Reg­u­la­to­ry Agency (MHRA) said Fri­day that it will restart its on­site in­spec­tions of drug man­u­fac­tur­ing sites on March 29.

MHRA made clear that the on­site in­spec­tions, which had been sus­pend­ed since Jan. 5, will on­ly oc­cur at sites that have been no­ti­fied at least two weeks in ad­vance un­less there are pub­lic health rea­sons that re­quire short­er no­tice or unan­nounced in­spec­tions. The reg­u­la­tor al­so said it will en­sure lim­it­ed face-to-face in­ter­ac­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER